Welcome, Oliwia!
Oliwia holds an MSc degree in Chemistry and is a specialist in molecular modeling. With her expertise, she’s strengthening both our laboratory and modeling teams
Jadwiga – a Guest Researcher at the University of Ljubljana
We’re proud to share that in February, our colleague Jadwiga Paszkowska was a Guest Researcher at the University of Ljubljana, Faculty of Pharmacy, Department of Biopharmaceutics and Pharmacokinetics.
Marcela has been awarded START scholarship
We are incredibly proud to share that our colleague Marcela Staniszewska has been awarded the prestigious START scholarship granted by the FNP Foundation for Polish Science! 🎉
15th PBP World Meeting, Prague, Czech Republic
We will be attending the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Prague, taking place March 23-26.
“The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance” conference by M-CERSI
Looking forward to an exciting talk by our colleagueDorota Danielak at the upcoming “The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance” conference by M-CERSI!
1st International PBPK Conference, Basel, Switzerland
Despite advances in physiologically based modeling, many approaches still assume homogeneous mixing of drug and gastric contents. Yet, real clinical data tell a different story—irregular plasma profiles, multiple secondary peaks, prolonged lag times, or unexpectedly early Cmax values.
DissoAmerica 2026, Somerset, NJ, USA
Our experts (Grzegorz Garbacz and Jadwiga Paszkowska) will be attending this year’s conference, organized by the Society for Pharmaceutical Dissolution Science, US Chapter, taking place:
PAGE 2026 in Dubrovnik, Croatia
We took a deep dive into how the novel Safe Space Designer tool handles physiological gastric emptying kinetics and evaluates bioequivalence (BE) risks. Our findings suggest that accounting for rapid gastric emptying patterns can lead to much more sensitive and robust BE predictions than traditional models.
CRS 2026, Porto, Portugal
Our CEO, Grzegorz Garbacz has been invited to speak at the Controlled Release Society